Birth Control

Telemedicine medical abortion service in Georgia: an evaluation of a strategy with reduced number of in-Clinic visits: The European Journal of Contraception & Reproductive Health Care: Vol 0, No 0

Abstract

Purpose

To evaluate the feasibility and acceptability of a medical abortion service that offers: a telemedicine visit (in lieu of an in-person visit) during a mandatory waiting period, and follow-up -up at home using multi-level pregnancy tests (MLPT).

Method

Participants were screened for eligibility at the clinic, and during the waiting period, received a phone call to confirm desire to continue with the service. Participants were mailed a study package containing mifepristone, misoprostol, two multi-level pregnancy tests, and instructions for their use. The follow-up consultation took place by telephone to check the completeness of the abortion. The analysis is descriptive.

Results

One hundred twenty-two participants were enrolled in the study, and 120 chose to continue with the abortion after the waiting period and were sent the study package. One participant was lost to follow up. The majority of participants did not experience problems receiving the study package (94.1%, n= 112), take mifepristone (100%, n= 119), misoprostol (99.2%, n= 118), and MLPTs (99.1%, n= 116) as instructed, and made additional clinic visits (91.6%, n= 109). All participants were satisfied with the service. Most participants had a complete abortion without a procedure (95.8%, n= 114).

Conclusions

A tailored telemedicine medical abortion service is feasible and satisfactory to participants and has the potential to make medical abortion more patient-centered where waiting periods are mandated.

Disclosure statement

The authors report no potential competing interests.

Additional information

Funding

This work was supported by Grand Challenges Canada.

Reprints and Company Permissions

Reminder: Choosing permissions is not provide access to the full text of the article, please see our help page
How do I view content?

To request reprint or company permissions for this article, please click on the relevant link below:

Academic Permissions

Reminder: Choosing permissions is not provide access to the full text of the article, please see our help page How do I view content?

Get permissions instantly through Rightslink by clicking the button below:

If you are unable to obtain permissions through Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button